Under the banner “Talent Without Limits”, 23 apprentices from across the University of St Andrews including the School of Medicine’s Business Administration apprentice, Rachel Horn enjoyed a fun day of team building…
On the 27th February James Joplin, the new Head of BHF Scotland visited the University of St Andrews to see the cutting edge medical and biomedical research carried out at the university. During the visit he met a…
Summer research experience with the John Bradley Clinical Research Programme Over the past summer, Amanda Kung (3rd year BSc student) participated in the John Bradley Clinical Research Programme in Toronto, Ontario.…
3rd year BHF-funded PhD student Amy Dorward (Pitt lab) and Dr Gavin Robertson (PDRA; Pitt lab) visited Prof Hiroshi Takeshima’s lab at the Graduate School of Pharmaceutical Science, Kyoto University, Japan between 9th…
The three students who were awarded Dorothy Miller Bursaries this year, Sofia Garcia Agudo, Sarah Alvi and Sarah Eshkour, gave great presentations about their experiences in Malawi this summer to an audience of…
The many threads of the School’s research and teaching activity in Malawi were represented at the Annual Scotland Malawi Partnership Member Awards event, which was held on the 5 September 2019 in Edinburgh’s City…
Funded by the European and Developing countries Clinical Trials Partnership (EDCTP), the two-year project brought together four institutions in Tanzania: National Institute of Medical Research (NIMR) through its Mbeya…
On Saturday 28th of September a team of staff from the School of Medicine delivered sessions on breathing, balance, heart and kidney dissections, prosthetic joints and recycling at Explorathon 2019 in Dundee Science…
Early diagnosis key to survival A new institute, created to help improve earlier diagnosis of cancer, cardiovascular disease, mental health and infection, has been launched at the University of St Andrews. Early…
Lung cancer is the most common cause of death from cancer in Scotland, with a quarter of all cancer deaths attributed to lung cancer. The current five-year survival rate is approximately 60% for stage I lung cancer but…